Lorcaserin Extended-Release Tablets and Ranibizumab ophthalmic
Determining the interaction of Lorcaserin Extended-Release Tablets and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Ranitidine
- Lorcaserin Extended-Release Tablets-Ranitidine Capsule
- Lorcaserin Extended-Release Tablets-Ranitidine Hydrochloride
- Lorcaserin Extended-Release Tablets-Ranitidine Injection
- Lorcaserin Extended-Release Tablets-Ranitidine Suspension
- Lorcaserin Extended-Release Tablets-Ranitidine Syrup
- Ranibizumab ophthalmic-Lorcaserin Hydrochloride
- Ranibizumab ophthalmic-Lorcaserin Tablets
- Ranibizumab ophthalmic-Lorcet
- Ranibizumab ophthalmic-Lorcet Plus
- Ranibizumab ophthalmic-Lorcet Tablets
- Ranibizumab ophthalmic-Lorlatinib